Clarius Mobile Health has received FDA clearance for its Clarius OB AI fetal biometric measurement tool, which aims to improve access to obstetrical prenatal monitoring and care, especially in resource-limited areas. The Clarius OB AI model, now available with the Clarius C3 HD3 wireless handheld ultrasound scanner in the United States and Canada, automates fetal biometry measurements to estimate fetal age, weight,…
Progyny, a provider of fertility, family building, and women’s health benefits, has announced its strategic acquisition of Apryl, a Berlin-based fertility benefits platform established in 2019. This move bolsters Progyny’s global offerings, providing enhanced guided, concierge support to employees worldwide as they navigate the complexities of fertility and family building care. Progyny’s comprehensive global benefits solution already supports multinational employers and their…
OCON Therapeutics has announced the successful completion of a $10 million investment round led by RH Capital. This funding will enhance OCON’s efforts to develop treatments for prevalent uterine pathologies using its proprietary 3D drug delivery system. The company focuses on developing drug delivery systems to address significant issues in women’s health. The company’s 3D stent drug delivery frame, IUB, has been…
In recognition of Men’s Health Month, Posterity Health has launched its Hormone Management Program across the United States. This program aims to address the issue of low testosterone (Low-T) among American males using best practice clinical protocols to ensure effective and personalized treatment. Low testosterone is a condition affecting over 3 million men in the U.S., with symptoms such as fatigue, poor…
Wisp, a company working in sexual and reproductive health, has taken a step forward by launching a new fertility vertical aimed at supporting women through every stage of their reproductive health journey. Through this strategic move Wisp wants to make healthcare more affordable and accessible for women, especially those facing challenges in conceiving. Fertility is a crucial aspect of women’s reproductive health,…
In a significant leadership shift, Gina Bartasi, the founder and executive chairman of Kindbody, has returned to her role as CEO to steer the company through its next phase of growth. Kindbody is known as a leading national fertility clinic network in the U.S. and global family-building benefits provider. Kindbody was founded by Bartasi in late 2018, and has grown into the…
YourChoice Therapeutics has achieved a significant milestone by completing its first-in-human clinical study for YCT-529, the pioneering hormone-free male birth control pill. Announced at the 2024 BIO International Convention, this development marks a breakthrough in contraceptive options, particularly for men. “We’re one step closer to delivering the world’s first male birth control pill,” said YourChoice Therapeutics Chief Science Officer Nadja Mannowetz. The…
Rhea, a global reproductive health services company, has officially launched, aiming to improve fertility journeys for modern families. The launch coincides with a follow-on funding round led by Thiel Capital, aimed at expanding Rhea’s global footprint and service offerings. Rhea is creating an end-to-end reproductive health ecosystem, connecting prospective families across Asia, North America, and Europe. The company’s services are centered around…
